Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Shares Outstanding (Diluted Average) (2021 - 2025)

Coeptis Therapeutics Holdings has reported Shares Outstanding (Diluted Average) over the past 5 years, most recently at $4.2 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $4.2 million for Q4 2025, up 120.03% from a year ago — trailing twelve months through Dec 2025 was $4.2 million (up 120.03% YoY), and the annual figure for FY2025 was $4.2 million, up 120.03%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $4.2 million at Coeptis Therapeutics Holdings, up from $3.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for COEPW hit a ceiling of $37.6 million in Q3 2024 and a floor of $1.3 million in Q4 2023.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $12.6 million (2022), compared with a mean of $14.1 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 583.49% in 2022 and later crashed 91.35% in 2025.
  • Coeptis Therapeutics Holdings' Shares Outstanding (Diluted Average) stood at $10.9 million in 2021, then skyrocketed by 30.98% to $14.3 million in 2022, then plummeted by 91.01% to $1.3 million in 2023, then skyrocketed by 49.84% to $1.9 million in 2024, then surged by 120.03% to $4.2 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $4.2 million (Q4 2025), $3.8 million (Q3 2025), and $3.4 million (Q2 2025) per Business Quant data.